Unicycive Therapeutics, Inc.
UNCY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001766140
No open-market purchases or sales by Unicycive Therapeutics, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $54.6M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Unicycive Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −2 vs. Q4 2024
- Shares held
- 59.9M
- −1.77M (−2.9%) vs. Q4 2024
- Total value
- $34.5M
- −$14.6M (−29.7%) vs. Q4 2024
- New holders
- 4
- 10 more added
- Sold out
- 6
- 8 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting UNCY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $54.6M |
| Q1 2026 | 51 | $65.2M |
| Q4 2025 | 35 | $47.5M |
| Q3 2025 | 30 | $27.4M |
| Q2 2025 | 20 | $24.6M |
| Q1 2025 | 29 | $34.5M |
| Q4 2024 | 31 | $49.0M |
| Q3 2024 | 29 | $19.1M |
| Q2 2024 | 24 | $9.52M |
| Q1 2024 | 23 | $31.6M |
| Q4 2023 | 16 | $11.3M |
| Q3 2023 | 16 | $12.2M |
| Q2 2023 | 15 | $1.38M |
| Q1 2023 | 13 | $3.54M |
| Q4 2022 | 9 | $428.3K |
| Q3 2022 | 12 | $571.0K |
| Q2 2022 | 15 | $992.0K |
| Q1 2022 | 12 | $1.48M |
| Q4 2021 | 12 | $2.30M |
| Q3 2021 | 10 | $3.02M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Unicycive Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 11,370,152 | $6.54M | 0.87% | +1,400,000+14.0% | Added |
| Great Point Partners LLC | 10,980,000 | $6.31M | 3.43% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 10,000,000 | $5.75M | 1.25% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 9,391,994 | $5.40M | 0.45% | −1,000,000−9.6% | Reduced |
| Logos Global Management LP | 5,078,927 | $2.92M | 0.52% | 00.0% | Unchanged |
| Walleye Capital LLC | 4,094,256 | $2.35M | 0.03% | −905,744−18.1% | Reduced |
| Silverarc Capital Management, LLC | 2,413,489 | $1.39M | 0.29% | −73,220−2.9% | Reduced |
| Acuta Capital Partners, LLC | 2,352,887 | $1.35M | 1.57% | +49,887+2.2% | Added |
| Alyeska Investment Group, L.P. | 1,750,000 | $1.01M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,212,441 | $697.2K | 0.00% | +74,221+6.5% | Added |
| Geode Capital Management, LLC | 579,202 | $333.0K | 0.00% | +54,715+10.4% | Added |
| State Street Corp | 125,236 | $72.0K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 123,233 | $70.8K | 0.00% | −48,230−28.1% | Reduced |
| Northern Trust Corp | 107,850 | $62.0K | 0.00% | +49,669+85.4% | Added |
| BlackRock, Inc. | 83,242 | $47.9K | 0.00% | +10,970+15.2% | Added |
| Goldman Sachs Group Inc | 73,475 | $42.2K | 0.00% | −133−0.2% | Reduced |
| Virtu Financial LLC | 38,868 | $22.0K | 0.00% | +38,868 | New |
| Cantor Fitzgerald, L. P. | 32,971 | $19.0K | 0.00% | +32,971 | New |
| Creative Planning | 25,910 | $14.9K | 0.00% | +3,236+14.3% | Added |
| Morgan Stanley | 22,266 | $12.8K | 0.00% | +17,266+345.3% | Added |
| HRT Financial LP | 17,816 | $10.0K | 0.00% | −4,315−19.5% | Reduced |
| Tandem Capital Management Corp | 15,500 | $8.91K | 0.00% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 14,840 | $8.53K | 0.00% | +14,840 | New |
| Two Sigma Securities, LLC | 12,044 | $6.92K | 0.00% | +12,044 | New |
| UBS Group AG | 9,552 | $5.49K | 0.00% | +9,551+955,100.0% | Added |
| Bank of America Corp | 428 | $246 | 0.00% | +22+5.4% | Added |
| JPMorgan Chase & Co | 184 | $106 | 0.00% | −15−7.5% | Reduced |
| Bogart Wealth, LLC | 60 | $34 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 25 | $14 | 0.00% | −24−49.0% | Reduced |
| Altium Capital Management LP | 0 | $0 | 0.00% | −1,473,000−100.0% | Sold out |
| Hunter Associates Investment Management LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −10,888−100.0% | Sold out |
| Family Wealth Group, LLC | 0 | $0 | 0.00% | −10,218−100.0% | Sold out |
| SOA Wealth Advisors, LLC. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −587−100.0% | Sold out |